Biotech News
GENFIT Annual Combined General Meeting of June 15, 2026 — Availability of Preparatory Documents
ir.genfit.com2026-05-11 17:02 EST
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 11, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it published in the May 11, 2026